Biostax Corp. (BTAX)

OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Mar 6, 2026, 9:30 AM EST
-99.00%
Market Cap 10.71K
Revenue (ttm) n/a
Net Income (ttm) -1.87M
Shares Out 107.11M
EPS (ttm) -0.02
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 2,194
Average Volume 24,528
Open 0.0001
Previous Close 0.0001
Day's Range 0.0001 - 0.0001
52-Week Range 0.0001 - 0.0002
Beta 0.78
RSI 28.84
Earnings Date Apr 13, 2026

About Biostax

Biostax Corp. operates as a biopharmaceutical company that acquires, develops, and commercializes pharmaceutical and biotechnology products. Its lead investigational drug candidate Lodonal, an once-a-day immune system regulator for the management of human immunodeficiency virus and acquired immune deficiency syndrome (HIV/AIDS). Its programs also include Global Telehealth platform; Medtech asset, an early development stage program that uses blockchain and smart contracts to manage and secure prescriptions and electronic health records; JKB-122,... [Read more]

Industry Biotechnology
Sector Healthcare
CEO Noreen Griffin
Employees 4
Stock Exchange OTCMKTS
Ticker Symbol BTAX
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.